Free CME from PeerView


Oncology CME

Medical Learning Institute, Inc.
Demystifying Cold Agglutinin Disease: A Visual Exploration of Mechanism, Diagnosis, and the Role of Complement Inhibition in Addressing Unmet Needs
Sigbjørn Berentsen, MD, PhD / Ilene C. Weitz, MD
December 08, 2022
Penn State College of Medicine
The Sequel to the Targeted Therapy Era in CML: Guidance on Integrating Novel Options Into Cohesive Sequential Care
Vivian G. Oehler, MD
December 08, 2022
PSU, Penn State University
Fixing the Target on Aggressive Lymphoma: Guidance on the Next Phase of Integrating Targeted Agents Into MCL and DLBCL Management
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD
December 08, 2022
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Erika Hamilton, MD
December 06, 2022
PVI, PeerView Institute for Medical Education
Personalizing Bladder Cancer Care in the Modern Therapeutic Era: One Size No Longer Fits All
Petros Grivas, MD, PhD
November 29, 2022
PVI, PeerView Institute for Medical Education
On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors
Bernd Kasper, MD, PhD
November 29, 2022
PVI, PeerView Institute for Medical Education
Case by Case: Maximizing Personalized Approaches to Prostate Cancer
Rana R. McKay, MD / Alicia K. Morgans, MD, MPH
November 29, 2022
PVI, PeerView Institute for Medical Education
Setting Our Sights on Improved Outcomes in Glioblastoma: State-of-the-Art Care With Tumor Treating Fields and Other Innovative Approaches
Steven Brem, MD
November 17, 2022
PVI, PeerView Institute for Medical Education
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments
Professor Peter Schmid, FRCP, MD, PhD
November 15, 2022
PVI, PeerView Institute for Medical Education
Getting to the Heart of Personalized ADT for Advanced Prostate Cancer: Are You Able to Leverage New Data and Therapy Options to Maximize Cardiovascular Safety and Treatment-Related Outcomes?
Daniel J. George, MD
November 14, 2022
PVI, PeerView Institute for Medical Education
Don’t Miss the Rare When Diagnosing and Treating Autoimmune Hemolytic Anemia: Focus on CAD
Morie A. Gertz, MD
November 08, 2022
Medical Learning Institute, Inc.
It Takes a Team for HCC: Improving Outcomes Through Multidisciplinary Collaboration & Modern Therapeutics
Amit Singal, MD, MS
November 04, 2022
PVI, PeerView Institute for Medical Education
Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Team-Based Strategies for Risk Assessment, Diagnosis, and Management of Myocarditis and Other Cardiac Immune-Related Adverse Events
Javid Moslehi, MD
November 04, 2022
PVI, PeerView Institute for Medical Education
RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World
Sumanta Kumar Pal, MD, FASCO
November 03, 2022
Medical Learning Institute, Inc.
Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient Care
Alicia K. Morgans, MD, MPH
October 30, 2022
PVI, PeerView Institute for Medical Education
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
Scott T. Tagawa, MD, MS, FACP
October 26, 2022
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 23, 2022
PVI, PeerView Institute for Medical Education
The Eye-Deal Connection in Multiple Myeloma: Establishing Ophthalmology-Oncology Relationships to Overcome Ocular Toxicity
Praneetha Thulasi, MD / Jonathan L. Kaufman, MD
September 30, 2022
PVI, PeerView Institute for Medical Education
Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right
Nasser Altorki, MD
September 29, 2022
PVI, PeerView Institute for Medical Education
An "Off-the-Shelf" Approach for Myeloma Care: Visualizing the Present and Future of BCMA Antibodies
Sagar Lonial, MD, FACP
September 29, 2022
PVI, PeerView Institute for Medical Education
SERDs at the Inflection Point in Pretreated ER+/HER2- Breast Cancer: Addressing Unmet Needs, Establishing New Standards of Care, and Improving Patient Outcomes With Novel ER-Targeting Therapies
Javier Cortes, MD, PhD
September 29, 2022
PVI, PeerView Institute for Medical Education
Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings
Brendon M. Stiles, MD
September 29, 2022
Medical Learning Institute, Inc.
Progress on the Path to Better Outcomes in RRMM: Expert Perspectives on the Further Integration of BCMA-Directed Antibodies and Cellular Therapies
Sagar Lonial, MD, FACP
September 28, 2022
PVI, PeerView Institute for Medical Education
Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Professor Aleix Prat, MD, PhD
September 28, 2022
Medical Learning Institute, Inc.
The Power of Personalized Medicine in AML: Linking Individualized Treatment to Enhanced Patient Outcomes
Naval Daver, MD / Amir T. Fathi, MD
September 28, 2022
Medical Learning Institute, Inc.
Challenges and Changes With Targeted Options in CLL: Guidance on Making Evidence-Informed Upfront and Sequential Treatment Choices
Nicole Lamanna, MD / Deborah M. Stephens, DO
September 28, 2022
Medical Learning Institute, Inc.
The “Innovation Moment” Arrives for MDS: Guidance on Building Personalized Management Plans to Improve Patient Outcomes
Guillermo Garcia-Manero, MD / Gail J. Roboz, MD
September 26, 2022
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
Marcia S. Brose, MD, PhD, FASCO
September 25, 2022
PVI, PeerView Institute for Medical Education
Refining Biomarker Testing and Targeted Treatment of NSCLC With Common and Uncommon EGFR Mutations
Natasha B. Leighl, MD, MMSc, FRCPC, FASCO
September 24, 2022
PVI, PeerView Institute for Medical Education
Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and Practical Considerations in Targeting HER2, HER3, TROP2, and Other Alterations in Advanced Lung Cancer
Marina Chiara Garassino, MD
September 24, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView